Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Transl Oncol
WY-14643 (Wy-14643
Followed by Combination Therapy with Dabrafenib and Trametinib for Metastatic Melanoma
4-phenylenebis(methylene))bis(pyrimidin-2-amine)
AS8351 was used at 1-10 µM in vitro and cellular assays
Poziotinib l (chloride) Transl OncolPoziotinib , also known as HM781 36B and NOV120101, is an orally bioavailable, quinazoline based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. HM781 36B irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. EGFRs, cell surface receptor tyrosine kinases, are often upregulated in a
US$ 450.00
US$ 90.00
US$ 110.00
US$ 70.00
US$ 347.50